Management of intrathecal catheter-tip inflammatory masses: An updated 2007 consensus statement from an expert panel

Neuromodulation

Volumn 11, Issue 2, 2008, Pages 77-91

  Deer, Timothy ^a,b   Krames, Elliot S ^a   Hassenbusch, Samuel ^a   Burton, Allen ^a   Caraway, David ^a   Dupen, Stuart ^a   Eisenach, James ^a   Erdek, Michael ^a   Grigsby, Eric ^a   Kim, Phillip ^a   Levy, Robert ^a   McDowell, Gladstone ^a   Mekhail, Nagy ^a   Panchal, Sunil ^a   Prager, Joshua ^a   Rauck, Richard ^a   Saulino, Michael ^a   Sitzman, Todd ^a   Staats, Peter ^a   Stanton Hicks, Michael ^a   Stearns, Lisa ^a   Dean Willis, K ^a   Witt, William ^a   Follett, Kenneth ^a   Huntoon, Mark ^a   Liem, Leong ^a   Rathmell, James ^a   Wallace, Mark ^a   Buchser, Eric ^a   Cousins, Michael ^a   Ver Donck, Ann ^a   more..

^a West Virginia University ^*

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Complications; Etiology; Granuloma formation; Intrathecal; Nonopioids; Opioids; Prevention; Treatment

Indexed keywords

ANALGESIC AGENT; BACLOFEN; BUPIVACAINE; CLONIDINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; FENTANYL; HYDROMORPHONE; METHADONE; MORPHINE; NALOXONE; OMEGA CONOTOXIN MVIIA; OPIATE; SUFENTANIL;

ANALGESIA; ANAMNESIS; ARTICLE; CATHETER COMPLICATION; CATHETER TIP GRANULOMA; CONSENSUS DEVELOPMENT; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG INFUSION; GRANULOMA; HUMAN; INFLAMMATION; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; QUADRIPLEGIA; RECOMMENDED DRUG DOSE; RISK MANAGEMENT;

EID: 41749114058     PISSN: 10947159     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1403.2008.00147.x     Document Type: Article

References (33)

1. Yaksh TL, Hassenbusch S, Burchiel K, Hildebrand KR, Page LM, Coffey RJ. Inflammatory masses associated with IT drug infusion: a review of preclinical evidence and human data. Pain Med 2002 3: 300 312.
2. Toombs JD, Follett KA, Rosenquist RW, Benton LM. IT catheter tip inflammatory mass: a failure of clonidine to protect. Anesthesiology 2005 102: 687 690.
3. North RB, Cutchis PN, Epstein JA et al. Spinal cord compression complicating subarachnoid infusion of morphine: case report and laboratory experience. Neurosurgery 1991 29: 778 784.
4. Schuchard M, Lanning R, North R, Reig E, Krames E. Neurologic sequelae of intraspinal drug delivery systems. results of a survey of American implanters of implantable drug delivery systems. Neuromodulation 1998 1: 137 148.
5. Hassenbusch S, Burchiel K, Coffey RJ et al. Management of IT catheter-tip inflammatory masses: a consensus statement. Pain Med 2002 3: 313 323.
6. Hassenbusch SJ, Portenoy RK, Cousins M et al. Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug deliver - report of an expert panel. J Pain Symptom Manage 2004 27: 540 563.
7. Hassenbusch SJ, Portenoy RK. Current practices in intraspinal therapy - a survey of clinical trends in decision making. J Pain Symptom Manage 2000 20: S4 S11.
8. Bennett G, Burchiel K, Buchser E et al. Clinical guidelines for intraspinal infusion: report of an expert panel. J Pain Symptom Manage 2000 20: S37 S43.
9. Bennett G, Serafini M, Burchiel K et al. Evidence based review of the literature on intrathecal delivery of pain medicine. J Pain Symptom Manage 2000 20: S12 S36.
10. Bennett G, Deer T, Du Pen S et al. Future directions in the management of pain by intraspinal drug delivery. J Pain Symptom Manage 2000 20: S44 S50.
11. Waara-Wolleat K, Hildebrand K, Stewart G. A review of IT fentanyl and sufentanil for the treatment of chronic pain. Pain Med 2006 7: 251 259.
12. Allen JW, Horais KA, Tozier NA et al. Time course and role of morphine dose and concentration in IT granuloma formation in dogs: a combined magnetic resonance imaging and histopathology investigation. Anesthesiology 2006 105: 581 589.
13. Horais K, Hruby V, Rossi S et al. Effects of chronic IT infusion of a partial differential opioid agonist in dogs. Toxicol Sci 2003 71: 263 275.
14. Yaksh TL, Horais KA, Tozier NA et al. Chronically infused IT morphine in dogs. Anesthesiology 2003 99: 174 187.
15. Coombs DW, Colburn RW, DeLeo JA, Hoopes PJ, Twitchell BB. Comparative spinal neuropathology of hydromorphone and morphine after 9- and 30-day epidural administration in sheep. Anesth Analg 1998 78: 674 681.
16. Johansen MJ, Satterfield WC, Baze WB et al. Continuous IT infusion of hydromorphone: safety in the sheep model and clinical implications. Pain Med 2004 5: 14 25.
17. Gradert TL, Baze WB, Satterfield WC, Hildebrand KR, Johansen MJ, Hassenbusch SJ. Safety of chronic IT morphine infusion in a sheep model. Anesthesiology 2003 99: 188 198.
18. Peng P, Massicotte EM. Spinal cord compression from IT catheter-tip inflammatory mass: case report and a review of etiology. Reg Anesth Pain Med 2004 29: 237 242.
19. Deer TR. A prospective analysis of IT granuloma in chronic pain patients: a review of the literature and report of a surveillance study. Pain Physician 2004 7: 225 228.
20. Anderson SR, Orbegozo M, Racz G, Raj PP. IT granuloma in patients receiving high-dose IT morphine therapy: a report of two cases. Pain Pract 2001 1: 61 67.
21. Miele VJ, Price KO, Bloomfield S, Hogg J, Bailes JE. A review of IT morphine therapy related granulomas. Eur J Pain 2006 10: 251 261.
22. Murphy PM, Skouvaklis DE, Amadeo RJ, Haberman C, Brazier DH, Cousins MJ. IT catheter granuloma associated with isolated baclofen infusion. Anesth Analg 2006 102: 848 852.
23. Fernandez J, Madison-Michael L, Feler C. Catheter tip granuloma associated with sacral region IT drug administration. Neuromodulation 2003 6 225 228.
24. Shields DC, Palma C, Khoo LT, Ferrante FM. Extramedullary IT catheter granuloma adherent to the conus medullaris presenting as cauda equina syndrome. Anesthesiology 2005 102: 1059 1061.
25. McMillan MR, Doud T, Nugent W. Catheter-associated masses in patients receiving IT analgesic therapy. Anesth Analg 2003 96: 186 190.
26. Wadhwa RK, Shaya MR, Nanda A. Spinal cord compression in a patient with a pain pump for failed back syndrome: a chalk-like precipitate mimicking a spinal cord neoplasm. Case Report. Neurosurgery 2006 58: E387.
27. Coffey RJ, Burchiel K. Inflammatory mass lesions associated with IT drug infusion catheters. report and observations on 41 patients. Neurosurgery 2002 50: 78 86.
28. Lehmberg J, Scheiwe C, Spreer J, van Velthoven V. Late bacterial granuloma at an IT drug delivery catheter. Acta Neurochir (Wien) 2006 148: 899 901.
29. Follett KA. IT analgesia and catheter-tip inflammatory masses. Anesthesiology 2003 99: 5 6.
30. Yaksh TL, Hassenbusch S, Burchiel K, Hildebrand KR, Page LM, Coffey RJ. Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data. Pain Med 2002 3: 300 312.
31. Dickson D. Risks and benefits of long-term intrathecal analgesia. Anaesthesia 2004 59: 633 635.
32. USP General Chapter 797. Pharmaceutical compounding - sterile preparations. U.S. Pharmacopeia, January 1, 2004.
33. American Society of Health-System Pharmacists. ASHP guideline on quality assurance for pharmacy-prepared sterile products. Am J Health Syst Pharm 2003 60: 1440 1446.